Clinical Trial Update: Pinpoint Trial: Prebiotics IN Peanut Oral ImmunoTherapy [Phase 1, Phase 2]

View source ↗

Summary

The Pinpoint Trial evaluating prebiotics in peanut oral immunotherapy for peanut allergy has completed Phase 1/Phase 2 with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peanut Allergy

Drugs mentioned

• Prebiotics IN Peanut Oral Immunotherapy

Snippet

Sponsor: University of Chicago | Conditions: Peanut Allergy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2026-03-09